Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Zerenex in ESRD
NCT00648167Phase 2Completed
- Sponsor
- Keryx Biopharmaceuticals, Inc.
- Start
- Mar 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric citrate in hyperphosphatemia, sponsored by Keryx Biopharmaceuticals, Inc.. Started Mar 2008; status: completed.
02
Drugs
ferric citrate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00648167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00648167.